South Dakota 2022 Regular Session

South Dakota Senate Bill SB17

Introduced
1/11/22  
Refer
1/11/22  
Report Pass
1/21/22  
Engrossed
1/25/22  
Refer
2/15/22  
Report Pass
2/23/22  
Enrolled
2/24/22  

Caption

Revise provisions regarding cost reimbursement associated with medical cannabis.

Impact

The bill's passage is expected to maintain the status quo for cannabis-related reimbursement policies and property rights concerning cannabis use. By clearly delineating the lack of obligation for reimbursement from health insurance providers and the rights of landlords in regard to cannabis, SB17 reinforces existing practices and could potentially curb the expansion of medical cannabis usage within certain contexts. This could result in economic implications for those invested in the medical cannabis market and related services, as reimbursements may not be forthcoming for patients or businesses involved in these operations.

Summary

Senate Bill 17 revises provisions regarding the cost reimbursement associated with the medical use of cannabis in South Dakota. Specifically, the bill states that no government medical assistance program or private health insurer is required to reimburse individuals for the costs incurred from using medical cannabis. Additionally, it clarifies that property owners are not obligated to allow the smoking of cannabis on their premises, nor are landlords required to permit the cultivation of cannabis on rental properties. This revision aims to define the boundaries of responsibility and liability for cannabis use and cultivation in the state.

Sentiment

The general sentiment around SB17 appears to be mixed but leans towards support among those favoring regulatory clarity. Supporters argue that the bill provides necessary definitions that promote responsible cannabis use while protecting landlords and insurers from potential liabilities. Critics, however, may view it as a restrictive measure that could hinder access to medical marijuana treatments, particularly for those relying on insurance coverage and suitable cultivation spaces. This divergence in sentiment may raise concerns about access to medical cannabis for vulnerable populations.

Contention

Notable points of contention surrounding SB17 may arise from advocates for medical cannabis who argue that the lack of reimbursement could limit access to treatment for patients who rely on insurance support for their medical needs. Furthermore, the restrictions placed on landlords concerning cultivation and usage could lead to legal challenges regarding property rights and tenant freedoms. Debates around this bill highlight broader discussions on cannabis legality, health care accessibility, and individual rights versus property rights, making it a significant point of discussion in the South Dakota legislative landscape.

Companion Bills

No companion bills found.

Previously Filed As

SD SB177

Revise provisions regarding medical cannabis.

SD SB190

Revise provisions regarding municipal zoning of medical cannabis establishments.

SD SB4

Revise provisions related to a written certification for the medical use of cannabis.

SD HB1056

Revise provisions related to medical cannabis data maintained by the Department of Health.

SD SB7

Revise provisions related to custody and visitation rights by medical cannabis cardholders.

SD SB42

Modify provisions related to medical cannabis.

SD SB21

Revise provisions related to the revocation of a medical cannabis registry identification card.

SD SB10

Revise provisions related to verifications required prior to receiving medical cannabis.

SD SB5

Revise acceptable conduct related to the medical use of cannabis.

SD SB6

Revise provisions related to prohibited conduct by schools and landlords related to medical cannabis.

Similar Bills

No similar bills found.